MedTrace Logo

Drug Use Investigation for XYZAL®

NCT01445262 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10728

Last updated 2015-08-13

No results posted yet for this study

Summary

This post-marketing surveillance study (PMS) is conducted to collect safety and efficacy data among subjects with allergic rhinitis, urticaria, eczema, dermatitis, skin irritation, prurigo or pruritus cutaneous who have never been treated with levocetirizine tablets before.

Conditions

  • Rhinitis, Allergic, Perennial and Seasonal

Interventions

DRUG

Levocetirizine

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-02-28
Primary Completion
2013-12-31
Completion
2013-12-31

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01445262 on ClinicalTrials.gov